Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.25 – $3.05
13% from low
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $20.6M | $26.1M | $3.2M | $5.0M | $6.4M | $7.7M | $9.1M | $8.0M |
| Cost of revenue | $16.0M | $11.1M | $2.9M | $4.1M | $5.1M | $4.8M | $6.4M | $7.2M |
| Gross profit | $4.6M | $14.9M | $347.9K | $880.8K | $1.2M | $2.9M | $2.7M | $806.5K |
| Gross margin | 22.2% | 57.3% | 10.8% | 17.8% | 19.7% | 37.3% | 29.8% | 10.1% |
| R&D | $0 | $0 | $0 | $0 | $0 | $162.9K | $865.6K | $673.1M |
| Operating income | −$823.8K | −$14.6M | −$20.7M | −$15.8M | −$11.5M | −$6.6M | −$23.3M | −$31.1M |
| EBITDA | −$11.4M | −$10.8M | −$36.6M | −$12.5M | −$8.8M | −$5.1M | −$11.8M | −$29.6M |
| Net income | −$30.6M | −$16.7M | −$45.1M | $62.9M | −$10.8M | −$3.4M | −$16.8M | −$32.8M |
| Net margin | -148.6% | -64.2% | -1403.3% | 1268.5% | -170.4% | -44.9% | -184.6% | -411.1% |
| EPS (diluted) | -2.64 | -1.04 | -1.57 | -0.38 | -0.28 | -0.10 | -0.45 | -0.83 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $23M | $-0.61 | $-0.61–$-0.61 | 1 |
| 2027 | $4M | $-0.40 | $-0.40–$-0.40 | 1 |
| 2028 | $700000 | $-0.25 | $-0.25–$-0.25 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds AGAE.
No tracked institution reports a position in AGAE as of their last filing.
No one on the platform has traded AGAE yet.
| $4M |
| — |
| LVOLiveOne, Inc. | $6.74 | +8.71% | $71M | — |
| OAMCFOverActive Media Corp. | $0.12 | -7.29% | $16M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 3.0× sales vs its 5.6× historical median P/S.
Fair value ≈ $1.17 · price $0.61 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$AIFA need to get people over here to new ticker name from $AGAE
View on StockTwits ↗$AGAE what’s the float on this one now? Take her to $20 lol
View on StockTwits ↗Three NASDAQ stocks with reverse splits scheduled on Friday. Expect trading to halt at 7:50pm ET tonight and resume at 9:00am ET Friday morning. $AERT 1 for 8. Will reduce outstanding Class A shares from approx 45.91m to approx 5.74m. $AIFA (formerly $AGAE) 1 for 6. Will reduce outstanding shares from approx 38.3m to approx 6.4m. $XXII 1 for 20. Will reduce outstanding shares from approx 10.33m (with 3.42m shares held in abeyance) to approx 516k (with 171k held in abeyance).
View on StockTwits ↗@noahloffredo @Stocktwits @michaelbozzello Please update the stream for $AGAE. It changed names and ticker a while back. New Name: All In FutureTech Alliance, Inc. New Ticker $AIFA https://www.globenewswire.com/news-release/2026/05/27/3302056/0/en/all-in-futuretech-alliance-inc-announces-nasdaq-approval-of-new-ticker-symbol-aifa-effective-immediately-underscoring-the-company-s-strategic-transition-toward-ai.html Thanks!!
View on StockTwits ↗$AIFA (formerly $AGAE) Equity Corporate Actions Alert #2026 - 397 Information Regarding the Reverse Stock Split and CUSIP Number Change for All In FutureTech Alliance, Inc. (AIFA) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-397 All In FutureTech Alliance, Inc. (AIFA) will effect a one-for-six (1-6) reverse split of its common stock. The reverse stock split will become effective on Friday, June 12, 2026. In conjunction with the reverse split, the CUSIP number will change to 019170208.
View on StockTwits ↗$AGAE I guess the plan is to have it open around $2 tomorrow
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.